Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A Phase III, Multicentre, Double-Blind, Randomised, Placebo-Controlled Study to Confirm the Safety and Efficacy of Subcutaneous Bioresorbable Afamelanotide Implants in Patients with Erythropoietic Protoporphyria (EPP) https://www.kusajili.fr:443/Trial/2hxVmbHoR0-4kNVjOQ3ssg%24a-phase-iii-multicentre-double-blind-randomised-placebo-controlled-study-to-confirm-the-safety-and-efficacy-of-subcutaneous-bio
I have read and accept the terms of use of the site and the Privacy Policy
Send your message